Delivery Order SPE2DB20D3101-SPE2DB25FRVN8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lynparza 150 mg tablets (120 count units) with a ceiling value of $42,270.40. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is scheduled for ultimate completion by September 15, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a delivery order valued at $36,747.69 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (60-unit packaging) under a firm fixed price contract. This non-set-aside award, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, represents a competitive procurement fulfilled by AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of LYNPARZA 150 mg tablets (60-count unit dose) with a ceiling value of $10,499.34. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lynparza 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lynparza 150 mg tablets (120 count) with a contract value of $10,567.60. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 2, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $31,702.80 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units) on September 16, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award under the company's broader pharmaceutical supply relationships with the federal government. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $21,135.20 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lynparza 150 mg tablets (120-count units). This firm fixed price, non-set-aside contract is scheduled for completion by October 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60 units. This contract, valued at $10,499.34, represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order through its...
- The Defense Logistics Agency awarded a delivery order valued at $10,499.34 to AmerisourceBergen Drug Corp for 60 tablets of Lynparza 150 mg, a specialty pharmaceutical product used in oncology treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,543.70 for 60 tablets of Lynparza 100 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader federal...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVN8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120 count units) with a contract value of $10,567.60. This firm fixed-price delivery order, awarded on September 15, 2025, is expected to be completed by October 6, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a comprehensive indefinite delivery vehicle that enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order for Lynparza, an oncology medication, exemplifies AmerisourceBergen's role in delivering specialty pharmaceuticals through the DLA's medical supply chain to support Defense Health Agency requirements and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/15/25 |